Search Results - "Kidney Neoplasms/mortality"
-
1
Authors: et al.
Contributors: et al.
Source: Acta Oncologica, Vol 64 (2025)
Acta oncologica
ACTA ONCOLOGICASubject Terms: Male, Immune Checkpoint Inhibitors/administration & dosage, Radiology, Nuclear Medicine and Imaging, Time Factors, Oncologie, THERAPY, Carcinoma, Renal Cell/secondary, immune checkpoint inhibitors, Antineoplastic Combined Chemotherapy Protocols, Medicine and Health Sciences, Ipilimumab/administration & dosage, Human health sciences, Kidney Neoplasms/mortality, Immune Checkpoint Inhibitors, RC254-282, Aged, 80 and over, OUTCOMES, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Carcinoma, Renal Cell/pathology, Hematology, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Middle Aged, Kidney Neoplasms, Progression-Free Survival, Renal cell carcinoma, Nivolumab/administration & dosage, treatment discontinuation, Carcinoma, Renal Cell/mortality, Kidney Neoplasms/drug therapy, Nivolumab, optimal treatment duration, Oncology, Female, Life Sciences & Biomedicine, Adult, DISCONTINUATION, Sciences de la santé humaine, Kidney Neoplasms/pathology, Immune Checkpoint Inhibitors/adverse effects, 3211 Oncology and carcinogenesis, Humans, 1112 Oncology and Carcinogenesis, Oncology & Carcinogenesis, Carcinoma, Renal Cell, Retrospective Studies, Aged, Science & Technology, Duration of Therapy, Immune Checkpoint Inhibitors/therapeutic use, Ipilimumab, MELANOMA PATIENTS, Carcinoma, Renal Cell/drug therapy, Human medicine, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Follow-Up Studies
File Description: application/pdf
Access URL: https://doaj.org/article/f0b66be9934249d38e034df42f696b62
https://hdl.handle.net/2268/335276
https://doi.org/10.2340/1651-226X.2025.43876
https://repository.uantwerpen.be/docstore/d:irua:30312
https://hdl.handle.net/10067/2161490151162165141
http://hdl.handle.net/1942/46632
http://hdl.handle.net/1854/LU-01K3QQRTE94KZYP1CX1X0WZ5CD
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD/file/01K42SV66F3YD38FGWT899GJ86
https://biblio.ugent.be/publication/01K3QQRTE94KZYP1CX1X0WZ5CD
http://doi.org/10.2340/1651-226x.2025.43876 -
2
Authors: et al.
Source: Ann Surg Oncol
Subject Terms: Male, Tumor grade, Cancer-specific mortality, Cell Dedifferentiation, Middle Aged, Prognosis, Nephrectomy, Renal cell carcinoma, Kidney Neoplasms, 3. Good health, Survival Rate, Sarcomatoid dedifferentiation, 03 medical and health sciences, 0302 clinical medicine, Female [MeSH], Follow-Up Studies [MeSH], Neoplasm Grading [MeSH], Aged [MeSH], SEER Program [MeSH], Humans [MeSH], Kidney Neoplasms/surgery [MeSH], Kidney Neoplasms/pathology [MeSH], Middle Aged [MeSH], Nephrectomy/mortality [MeSH], Survival Rate [MeSH], Carcinoma, Renal Cell/mortality [MeSH], Urologic Oncology, Male [MeSH], Kidney Neoplasms/mortality [MeSH], Prognosis [MeSH], Carcinoma, Renal Cell/pathology [MeSH], Carcinoma, Renal Cell/surgery [MeSH], Cell Dedifferentiation [MeSH], Humans, Female, Neoplasm Grading, Carcinoma, Renal Cell, Aged, Follow-Up Studies, SEER Program
-
3
Authors: et al.
Contributors: et al.
Source: Cancer Immunol Immunother
Cancer Immunology, Immunotherapy, Vol 74, Iss 2, Pp 1-11 (2025)Subject Terms: Adult, Male, ARON-1 study, Good favorable-risk IMDC criteria, Immune-based combinations, Immunotherapy, Renal cell carcinoma, Pyridines, Risk Factors, Antineoplastic Combined Chemotherapy Protocols, Sunitinib, Humans, Neoplasm Metastasis, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Protein Kinase Inhibitors, RC254-282, Aged, Retrospective Studies, Immune-based combination, Research, Phenylurea Compounds, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Pyridines [MeSH], Kidney Neoplasms/immunology [MeSH], Phenylurea Compounds/therapeutic use [MeSH], Aged [MeSH], Kidney Neoplasms/pathology [MeSH], Risk Factors [MeSH], Carcinoma, Renal Cell/mortality [MeSH], Male [MeSH], Kidney Neoplasms/mortality [MeSH], Female [MeSH], Quinolines/therapeutic use [MeSH], Adult [MeSH], Humans [MeSH], Neoplasm Metastasis [MeSH], Sunitinib/therapeutic use [MeSH], Carcinoma, Renal Cell/immunology [MeSH], Retrospective Studies [MeSH], Middle Aged [MeSH], Protein Kinase Inhibitors/therapeutic use [MeSH], Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Kidney Neoplasms/drug therapy [MeSH], Carcinoma, Renal Cell/drug therapy [MeSH], Prognosis [MeSH], Quinolines/administration, Phenylurea Compounds/administration, Middle Aged, Prognosis, Kidney Neoplasms, Settore MEDS-09/A - Oncologia medica, Quinolines, Female
File Description: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
-
4
Authors: et al.
Source: Ann Surg Oncol
Subject Terms: Male, Heart Valve Prosthesis Implantation, Length of Stay/statistics, Comorbidities, Aged [MeSH], Heart-valve replacement, Postoperative Complications/mortality [MeSH], Kidney Neoplasms/pathology [MeSH], Risk Factors [MeSH], Heart Valve Prosthesis Implantation/mortality [MeSH], Nephrectomy/mortality [MeSH], Hospital Mortality [MeSH], Nephrectomy/methods [MeSH], Male [MeSH], Intraoperative Complications/mortality [MeSH], Kidney Neoplasms/mortality [MeSH], Nephrectomy/adverse effects [MeSH], Heart surgery, Postoperative Complications/etiology [MeSH], NIS, Female [MeSH], Follow-Up Studies [MeSH], Humans [MeSH], Kidney Neoplasms/surgery [MeSH], Middle Aged [MeSH], Kidney cancer, Survival Rate [MeSH], Heart Valve Prosthesis Implantation/adverse effects [MeSH], Urologic Oncology, Prognosis [MeSH], Middle Aged, Length of Stay, Prognosis, Nephrectomy, Kidney Neoplasms, Survival Rate, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Risk Factors, Humans, Female, Hospital Mortality, Intraoperative Complications, Aged, Follow-Up Studies
-
5
Authors: et al.
Contributors: et al.
Source: Cancer Immunol Immunother
Subject Terms: Male, Adult, 0301 basic medicine, Pulmonary and Respiratory Medicine, Adolescent, Population, NCT05287464, Cancer Immunotherapy, Young Adult, 03 medical and health sciences, Sex Factors, 0302 clinical medicine, Observational study, Antineoplastic Combined Chemotherapy Protocols, Health Sciences, ARON-1 study, Gender difference, Humans, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Diagnosis and Treatment of Bladder Cancer, Internal medicine, Aged, Aged, 80 and over, Aged, 80 and over [MeSH], Kidney Neoplasms/immunology [MeSH], Aged [MeSH], Kidney Neoplasms/pathology [MeSH], Carcinoma, Renal Cell/mortality [MeSH], Immunotherapy/methods [MeSH], Male [MeSH], Renal cell carcinoma, Kidney Neoplasms/mortality [MeSH], Sex Factors [MeSH], Gender differences, Adolescent [MeSH], Female [MeSH], Adult [MeSH], Humans [MeSH], Carcinoma, Renal Cell/immunology [MeSH], Middle Aged [MeSH], Immune-based combinations, Antineoplastic Combined Chemotherapy Protocols/therapeutic use [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Kidney Neoplasms/drug therapy [MeSH], Survival Rate [MeSH], Carcinoma, Renal Cell/drug therapy [MeSH], Research, Immunotherapy, Prognosis [MeSH], Young Adult [MeSH], Carcinoma, Renal Cell/pathology [MeSH], Immune-based combination, Renal Cell Carcinoma, Gastroenterology, Middle Aged, Prognosis, Kidney Neoplasms, 3. Good health, Survival Rate, Environmental health, Oncology, Medicine, Female, Surgery
File Description: application/pdf; application/vnd.openxmlformats-officedocument.wordprocessingml.document
Access URL: https://pubmed.ncbi.nlm.nih.gov/38832989
https://repository.publisso.de/resource/frl:6524368
https://link.springer.com/article/10.1007/s00262-024-03719-0
https://doi.org/10.1007/s00262-024-03719-0
https://hdl.handle.net/11585/971115
https://hdl.handle.net/2158/1365114
https://doi.org/10.1007/s00262-024-03719-0 -
6
Authors: et al.
Source: World J Urol
Subject Terms: Carcinoma, Transitional Cell, 03 medical and health sciences, Invited Review, 0302 clinical medicine, Ureteral Neoplasms, Ureteroscopy, Humans, Nephron-sparing surgery, Ureteral Neoplasms/pathology [MeSH], Humans [MeSH], Kidney Neoplasms/surgery [MeSH], Kidney Neoplasms/pathology [MeSH], Ureteroscopy/methods [MeSH], Radical nephroureterectomy, Carcinoma, Transitional Cell/pathology [MeSH], Ureteral Neoplasms/surgery [MeSH], Survival, Nephroureterectomy/methods [MeSH], Endoscopic treatment, Kidney Neoplasms/mortality [MeSH], Ureteral Neoplasms/mortality [MeSH], Carcinoma, Transitional Cell/surgery [MeSH], Carcinoma, Transitional Cell/mortality [MeSH], Localized upper urinary tract urothelial carcinoma, Nephroureterectomy, Kidney Neoplasms
-
7
Authors: et al.
Contributors: et al.
Source: NEW ENGLAND JOURNAL OF MEDICINE
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Institut dInvestigació Biomèdica Sant Pau (IIB Sant Pau)Subject Terms: 0301 basic medicine, Male, Protein Kinase Inhibitors/therapeutic use, Programmed Cell Death 1 Receptor, Quinoline, Medizin, Oncologie, lenvatinib, Antineoplastic Agent, Renal Cell / mortality, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols / adverse effects, Monoclonal, Antineoplastic Combined Chemotherapy Protocols, 80 and over, Sunitinib, Everolimus/administration & dosage, Human health sciences, Protein Kinase Inhibitors / therapeutic use, Phenylurea Compounds/adverse effects, Humanized, Kidney Neoplasms/mortality, Aged, 80 and over, Medicine (all), Programmed Cell Death 1 Receptor/antagonists & inhibitors, Antineoplastic Combined Chemotherapy Protocols / therapeutic use, Kidney Neoplasm, General Medicine, Middle Aged, Phenylurea Compounds / adverse effects, Kidney Neoplasms, Progression-Free Survival, Kidney Neoplasms / mortality, 3. Good health, Everolimu, Carcinoma, Renal Cell/mortality, Kidney Neoplasms/drug therapy, Sunitinib/adverse effects, Oncology, Antibodies, Monoclonal, Humanized/adverse effects, Quinolines, Humanized / administration & dosage, Female, pembrolizumab, Quinolines / administration & dosage, Human, Antibodies, Monoclonal, Humanized/administration & dosage, Phenylurea Compound, Adult, Quinolines / adverse effects, Humanized / adverse effects, Everolimus/adverse effects, Protein Kinase Inhibitor, Quinolines/administration & dosage, Antineoplastic Agents, Sunitinib/therapeutic use, Antibodies, Monoclonal, Humanized, Phenylurea Compounds / administration & dosage, Sciences de la santé humaine, Everolimus / administration & dosage, Antibodies, 03 medical and health sciences, Humans, Everolimus, Carcinoma, Renal Cell, Protein Kinase Inhibitors, Quinolines/adverse effects, Aged, Antineoplastic Combined Chemotherapy Protocol, Programmed Cell Death 1 Receptor / antagonists & inhibitors, Everolimus / adverse effects, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Phenylurea Compounds, Antineoplastic Agents / adverse effects, Carcinoma, Antineoplastic Agents/therapeutic use, Sunitinib / therapeutic use, Renal Cell, Renal Cell / drug therapy, Antineoplastic Agents/adverse effects, Antineoplastic Agents / therapeutic use, Survival Analysis, Phenylurea Compounds/administration & dosage, Sunitinib / adverse effects, Carcinoma, Renal Cell/drug therapy, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Kidney Neoplasms / drug therapy
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/33616314
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=4803
https://kyushu-u.pure.elsevier.com/ja/publications/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-ce
https://miami.pure.elsevier.com/en/publications/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-ce
https://www.ncbi.nlm.nih.gov/pubmed/33616314
https://www.nejm.org/doi/full/10.1056/NEJMoa2035716
https://moh-it.pure.elsevier.com/en/publications/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-ce
https://digitalcommons.psjhealth.org/publications/4788/
https://www.nejm.org/doi/full/10.1056/NEJMoa2035716
https://doi.org/10.1056/NEJMoa2035716
https://hdl.handle.net/2268/300816
https://doi.org/10.1056/NEJMoa2035716
https://hdl.handle.net/11567/1046356
https://doi.org/10.1056/NEJMoa2035716
https://hdl.handle.net/11587/542826
https://doi.org/10.1056/NEJMoa2035716
https://www.ncbi.nlm.nih.gov/pubmed/33616314
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85103105017
https://doi.org/10.1056/NEJMoa2035716 -
8
Authors: et al.
Contributors: et al.
Source: Journal of Urology. 206:568-576
Subject Terms: Biopsy / adverse effects, Male, Kidney / pathology, Biopsy, Urinary Bladder Neoplasms / epidemiology, Kidney, Nephroureterectomy, 0302 clinical medicine, Robotic Surgical Procedures, Risk Factors, robotic surgical procedures, ureteral neoplasms, urinary bladder neoplasms, Transitional Cell / secondary, Urinary Bladder / pathology, Margins of Excision, Middle Aged, Ureter / pathology, Kidney Neoplasms, Kidney Neoplasms / mortality, 3. Good health, Robotic Surgical Procedures / adverse effects, Aged, Carcinoma, Transitional Cell, Disease-Free Survival, Female, Follow-Up Studies, Humans, Neoplasm Seeding, Proportional Hazards Models, Retrospective Studies, Ureter, Ureteral Neoplasms, Ureteroscopy, Urinary Bladder, Urinary Bladder Neoplasms, Transitional Cell / surgery, Ureteral Neoplasms / diagnosis, Ureteral Neoplasms / surgery, Transitional Cell / diagnosis, Kidney Neoplasms / diagnosis, 03 medical and health sciences, Ureteroscopy / adverse effects, Transitional Cell / epidemiology, Kidney Neoplasms / surgery, Carcinoma, Nephroureterectomy / adverse effects, Ureter / surgery, Urinary Bladder Neoplasms / secondary, Biopsy / methods, Nephroureterectomy / methods, Kidney / surgery, Ureteral Neoplasms / mortality, Urinary Bladder Neoplasms / diagnosis
File Description: application/pdf
Access URL: https://pubmed.ncbi.nlm.nih.gov/33881931
https://europepmc.org/article/MED/33881931
https://pubmed.ncbi.nlm.nih.gov/33881931/
https://moh-it.pure.elsevier.com/en/publications/risk-factors-for-intravesical-recurrence-after-minimally-invasive
https://www.auajournals.org/doi/10.1097/JU.0000000000001786
https://www.ncbi.nlm.nih.gov/pubmed/33881931
https://scholarlycommons.henryford.com/urology_articles/401/
https://hdl.handle.net/2434/1127350
https://doi.org/10.1097/JU.0000000000001786
https://hdl.handle.net/2158/1287583
https://doi.org/10.1097/JU.0000000000001786 -
9
Authors: et al.
Contributors: et al.
Source: Maggen, C, Linssen, J, Gziri, M M, Zola, P, Cardonick, E, de Groot, C J M, Garcia, A C, Fruscio, R, Drochytek, V, Van Calsteren, K, Albersen, M, Amant, F & for the International Network on Cancer, Infertility and Pregnancy (INCIP). 2021, 'Renal and Bladder Cancer During Pregnancy : A Review of 47 Cases and Literature-based Recommendations for Management', Urology, vol. 151, pp. 118-128. https://doi.org/10.1016/j.urology.2020.08.084
Urology, Vol. 151, p. 118-128 (2021)Subject Terms: Renal cancer, bladder cancer, pregnancy, Adult, Pain, Pain/etiology, Young Adult, 03 medical and health sciences, 0302 clinical medicine, TUMOR, Pregnancy, Humans, Labor, Induced, Registries, Kidney Neoplasms/mortality, Hematuria, Retrospective Studies, Science & Technology, WOMAN, Pregnancy Complications, Neoplastic/mortality, 2ND TRIMESTER, 3202 Clinical sciences, Infant, Newborn, 1103 Clinical Sciences, Urology & Nephrology, CELL CARCINOMA, RADICAL NEPHRECTOMY, Middle Aged, International Network on Cancer, Infertility and Pregnancy (INCIP), CARCINOMA COMPLICATING PREGNANCY, Kidney Neoplasms, 3. Good health, Hematuria/etiology, Urinary Bladder Neoplasms, Urinary Bladder Neoplasms/mortality, young adult, Premature Birth, Female, Life Sciences & Biomedicine, Pregnancy Complications, Neoplastic
Access URL: https://lirias.kuleuven.be/bitstream/20.500.12942/690427/2/Urological%20cancers%20pregnancy.pdf
https://pubmed.ncbi.nlm.nih.gov/33203520
https://www.narcis.nl/publication/RecordID/oai%3Apure.atira.dk%3Apublications%2Fd0cc31e1-f4fb-4feb-afe2-fd5d4cf33b2b
https://www.sciencedirect.com/science/article/pii/S0090429520312711
https://research.vumc.nl/en/publications/renal-and-bladder-cancer-during-pregnancy-a-review-of-47-cases-an
https://pubmed.ncbi.nlm.nih.gov/33203520/
https://www.ncbi.nlm.nih.gov/pubmed/33203520
https://europepmc.org/article/MED/33203520
https://research.vumc.nl/en/publications/d0cc31e1-f4fb-4feb-afe2-fd5d4cf33b2b
https://hdl.handle.net/2078.1/268367
https://biblio.vub.ac.be/vubir/(75fada73-a660-4c4d-9dc6-b5c15cb80c59).html -
10
Authors: et al.
Contributors: et al.
Source: Virchows Archiv. 478:459-470
Subject Terms: Male, 0301 basic medicine, Renal oncocytoma, Oxyphilic / mortality, HNF-1β, Chromophobe renal cell carcinoma, Renal Cell / mortality, Renal Cell / therapy, 0302 clinical medicine, Diagnosis, 80 and over, Adenoma, Oxyphilic, Kidney Neoplasms / chemistry, Oxyphilic / therapy, Aged, 80 and over, Kidney Neoplasms / therapy, Oxyphilic / chemistry, Middle Aged, Prognosis, Immunohistochemistry, Kidney Neoplasms, Kidney Neoplasms / mortality, 3. Good health, Proto-Oncogene Proteins c-kit, CD10, Female, Kidney Neoplasms / pathology, Oxyphilic / pathology, Adenoma, Adult, Down-Regulation, Hepatocyte Nuclear Factor 1-beta / analysis, Diagnosis, Differential, 03 medical and health sciences, Predictive Value of Tests, Biomarkers, Tumor, Tumor / analysis, Humans, Proto-Oncogene Proteins c-kit / analysis, Carcinoma, Renal Cell, Aged, Hepatocyte Nuclear Factor 1-beta, Keratin-7 / analysis, Renal Cell / pathology, Carcinoma, Keratin-7, Renal Cell / chemistry, Marker, Differential, Biomarkers
Access URL: https://link.springer.com/article/10.1007/s00428-020-02912-7
https://pubmed.ncbi.nlm.nih.gov/32816058
https://pubmed.ncbi.nlm.nih.gov/32816058/
https://yonsei.pure.elsevier.com/en/publications/hnf-1%CE%B2-as-an-immunohistochemical-marker-for-distinguishing-chromo
https://link.springer.com/article/10.1007/s00428-020-02912-7
https://www.ncbi.nlm.nih.gov/pubmed/32816058
https://europepmc.org/article/MED/32816058 -
11
Authors: et al.
Source: Target Oncol
Target. Oncol. 15, 377-390 (2020)Subject Terms: Male, 0301 basic medicine, 0303 health sciences, Female [MeSH], Humans [MeSH], Progression-Free Survival [MeSH], Survival Analysis [MeSH], Kidney Neoplasms/pathology [MeSH], Middle Aged [MeSH], Oncology, B7-H1 Antigen/metabolism [MeSH], Immune Checkpoint Inhibitors/therapeutic use [MeSH], Carcinoma, Renal Cell/mortality [MeSH], Interferon-gamma/genetics [MeSH], Male [MeSH], Kidney Neoplasms/genetics [MeSH], Kidney Neoplasms/mortality [MeSH], Biomedicine, general, Signal Transduction [MeSH], Original Research Article, Carcinoma, Renal Cell/pathology [MeSH], Carcinoma, Renal Cell/genetics [MeSH], Immune Checkpoint Inhibitors/pharmacology [MeSH], Middle Aged, Survival Analysis, B7-H1 Antigen, Kidney Neoplasms, Progression-Free Survival, 3. Good health, Interferon-gamma, 03 medical and health sciences, Humans, Female, Carcinoma, Renal Cell, Immune Checkpoint Inhibitors, Signal Transduction
File Description: application/pdf
Access URL: https://link.springer.com/content/pdf/10.1007/s11523-020-00728-8.pdf
https://pubmed.ncbi.nlm.nih.gov/32495158
https://link.springer.com/article/10.1007/s11523-020-00728-8
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283197/
https://pubmed.ncbi.nlm.nih.gov/32495158/
http://europepmc.org/article/MED/32495158
https://link.springer.com/content/pdf/10.1007/s11523-020-00728-8.pdf
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=59352
https://repository.publisso.de/resource/frl:6465045 -
12
Authors: et al.
Source: World J Urol
Subject Terms: Aged, 80 and over, Ploidies, DNA, Neoplasm, Middle Aged, Prognosis, Kidney Neoplasms, 3. Good health, DNA, Neoplasm/analysis [MeSH], Ploidies [MeSH], Aged, 80 and over [MeSH], Aged [MeSH], Humans [MeSH], Kidney Neoplasms/chemistry [MeSH], Retrospective Studies [MeSH], Carcinoma, Renal Cell/chemistry [MeSH], Middle Aged [MeSH], DNA, Neoplasm/genetics [MeSH], Original Article, Survival Rate [MeSH], Carcinoma, Renal Cell/mortality [MeSH], Kidney Neoplasms/genetics [MeSH], Kidney Neoplasms/mortality [MeSH], Prognosis [MeSH], DNA ploidy, Renal cell cancer, Flow cytometry, Carcinoma, Renal Cell/genetics [MeSH], Survival Rate, 03 medical and health sciences, 0302 clinical medicine, Humans, Carcinoma, Renal Cell, Aged, Retrospective Studies
Access URL: https://link.springer.com/content/pdf/10.1007/s00345-020-03226-8.pdf
https://pubmed.ncbi.nlm.nih.gov/32361874
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969487
https://link.springer.com/article/10.1007/s00345-020-03226-8
https://europepmc.org/articles/PMC7969487/
https://www.ncbi.nlm.nih.gov/pubmed/32361874
https://link.springer.com/content/pdf/10.1007/s00345-020-03226-8.pdf
https://repository.publisso.de/resource/frl:6466828 -
13
Authors: et al.
Source: Oncogene
Subject Terms: Male, 0301 basic medicine, Carcinogenesis, Haploinsufficiency, Kaplan-Meier Estimate, Kidney, Article, Mice, 03 medical and health sciences, Cell Line, Tumor, Biomarkers, Tumor, Animals, Humans, Gene Silencing, Gene Expression Regulation, Neoplastic [MeSH], Cell Line, Tumor [MeSH], Disease Progression [MeSH], Tumor Suppressor Proteins/genetics [MeSH], Haploinsufficiency [MeSH], Kidney Neoplasms/pathology [MeSH], Up-Regulation [MeSH], Kidney Neoplasms/diagnosis [MeSH], Male [MeSH], Renal cell carcinoma, Kidney Neoplasms/genetics [MeSH], Kidney Neoplasms/mortality [MeSH], DNA methylation, Kidney/pathology [MeSH], Disease Models, Animal [MeSH], Kaplan-Meier Estimate [MeSH], Humans [MeSH], Animals [MeSH], Gene Silencing [MeSH], Mice, Knockout [MeSH], CpG Islands/genetics [MeSH], Promoter Regions, Genetic/genetics [MeSH], Mice [MeSH], DNA Methylation [MeSH], Cancer genetics, Biomarkers, Tumor/genetics [MeSH], HEK293 Cells [MeSH], Prognosis [MeSH], Carcinogenesis/genetics [MeSH], Mice, Knockout, 0303 health sciences, DNA Methylation, Prognosis, Kidney Neoplasms, 3. Good health, Gene Expression Regulation, Neoplastic, Disease Models, Animal, HEK293 Cells, Disease Progression, CpG Islands, ddc:570
File Description: application/pdf
Access URL: https://www.nature.com/articles/s41388-020-1195-6.pdf
https://pubmed.ncbi.nlm.nih.gov/32047266
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7142015
https://pubmed.ncbi.nlm.nih.gov/32047266/
https://www.nature.com/articles/s41388-020-1195-6.pdf
https://www.nature.com/articles/s41388-020-1195-6
https://pure.mpg.de/pubman/faces/ViewItemOverviewPage.jsp?itemId=item_3242568
https://europepmc.org/article/MED/32047266
https://repository.publisso.de/resource/frl:6471368 -
14
Authors: et al.
Subject Terms: Aged, Carcinoma, Renal Cell/genetics, Renal Cell/mortality, Female, Genes, Neoplasm/genetics, Humans, Kidney Neoplasms/genetics, Kidney Neoplasms/mortality, Male, Middle Aged, Models, Genetic, Mutation, Prognosis, Reproducibility of Results, Retrospective Studies, Survival Rate, DNA copy number variations, DNA mutational analysis, kidney, renal cell
Relation: The Journal of urology; https://iris.unil.ch/handle/iris/135475; serval:BIB_BF35109D0586; 000342082600006
-
15
Authors: et al.
Subject Terms: Adult, Age Distribution, Epidemiologic Methods, Europe/epidemiology, Female, Humans, Kidney Neoplasms/mortality, Male, Middle Aged, Sex Factors, Europe
Relation: BJU International; https://iris.unil.ch/handle/iris/109708; serval:BIB_24A9432BD34A; 000254189400006
-
16
Authors: et al.
Contributors: et al.
Source: Journal of Cancer Research and Clinical Oncology. 145:957-965
Subject Terms: Adult, Male, Kidney Neoplasms/surgery, Nutritional Status, Kaplan-Meier Estimate, Cholesterol/blood, Nephrectomy, Renal Cell/blood, Disease-Free Survival, Serum Albumin/metabolism, 03 medical and health sciences, 0302 clinical medicine, Predictive Value of Tests, Kidney Neoplasms/blood, 80 and over, Humans, Non-metastatic clear cell renal cell carcinoma, Lymphocyte Count, Kidney Neoplasms/mortality, Carcinoma, Renal Cell, Serum Albumin, Nutrition, Aged, Retrospective Studies, Aged, 80 and over, 2. Zero hunger, Renal Cell/surgery, Carcinoma, Immunity, Renal Cell/mortality, Middle Aged, Renal Cell/immunology, Kidney Neoplasms/immunology, Kidney Neoplasms, 3. Good health, Cholesterol, Preoperative Period, Female
Access URL: https://pubmed.ncbi.nlm.nih.gov/30758671
https://europepmc.org/article/MED/30758671
https://ir.ymlib.yonsei.ac.kr/handle/22282913/169845
https://pubmed.ncbi.nlm.nih.gov/30758671/
https://link.springer.com/article/10.1007/s00432-019-02846-x
https://www.ncbi.nlm.nih.gov/pubmed/30758671
https://yonsei.pure.elsevier.com/en/publications/preoperative-controlling-nutritional-status-conut-score-as-a-nove -
17
Authors: et al.
Source: Nisen, H, Järvinen, P, Fovaeus, M, Guðmundsson, E, Kromann-Andersen, B, Ljungberg, B, Lund, L, Nilsen, F, Sundqvist, P & Beisland, C 2017, ' Contemporary treatment of renal tumors : a questionnaire survey in the Nordic countries (the NORENCA-I study) ', Scandinavian Journal of Urology and Nephrology, vol. 51, no. 5, pp. 360-366 . https://doi.org/10.1080/21681805.2017.1326524
Subject Terms: Hospitals, District/statistics & numerical data, Postoperative Complications/epidemiology, Ablation Techniques, Nephrectomy/adverse effects, Hospitals, Low-Volume, Hospitals, Teaching/statistics & numerical data, minimally invasive methods, Scandinavian and Nordic Countries, Nephrectomy, surgery, 03 medical and health sciences, Postoperative Complications, 0302 clinical medicine, Robotic Surgical Procedures, Surveys and Questionnaires, nephrectomy, Humans, Hospitals, Teaching, Kidney Neoplasms/mortality, Robotic Surgical Procedures/adverse effects, Simulation Training, High-Volume/statistics & numerical data, District/statistics & numerical data, kidney cancer, Hospitals/statistics & numerical data, Low-Volume/statistics & numerical data, Length of Stay, Hospitals, District, mortality, Hospitals, Kidney Neoplasms, Scandinavian and Nordic Countries/epidemiology, 3. Good health, Hospitals, High-Volume/statistics & numerical data, Length of Stay/statistics & numerical data, Laparoscopy/adverse effects, Laparoscopy, Hospitals, Low-Volume/statistics & numerical data, Simulation Training/statistics & numerical data, Teaching/statistics & numerical data, Complication, Hospitals, High-Volume, Ablation Techniques/adverse effects
Access URL: https://pubmed.ncbi.nlm.nih.gov/28644697
https://www.tandfonline.com/doi/full/10.1080/21681805.2017.1326524
https://pubmed.ncbi.nlm.nih.gov/28644697/
http://umu.diva-portal.org/smash/record.jsf?pid=diva2:1162295
https://core.ac.uk/display/149219485
http://www.diva-portal.org/smash/record.jsf?pid=diva2:1148292
https://portal.findresearcher.sdu.dk/da/publications/contemporary-treatment-of-renal-tumors-a-questionnaire-survey-in-
https://portal.findresearcher.sdu.dk/da/publications/782afca1-d21a-4328-b1f4-4d6a6896bf1f -
18
Authors: et al.
Source: Rochester Regional Health authored publications and proceedings
Subject Terms: Age-adjusted mortality, CDC, Crude mortality, Renal cancer, Humans, United States (epidemiology), White People (statistics & numerical data), Kidney Neoplasms (mortality, ethnology), Black or African American (statistics & numerical data), Male, Aged, Female, Middle Aged, Health Status Disparities, Adult, 80 and over, Medicine and Health Sciences
Relation: https://scholar.rochesterregional.org/rrhpubs/2426; https://doi.org/10.1016/j.jgo.2024.101797
-
19
Authors: et al.
Source: Oncotarget
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Universidad de Zaragoza
instname
Rabjerg, M, Guerra, B, Oliván-Viguera, A, Mikkelsen, M L N, Köhler, R, Issinger, O G & Marcussen, N 2017, ' Nuclear localization of the CK2α-subunit correlates with poor prognosis in Clear Cell Renal Cell Carcinoma ', Oncotarget, vol. 8, no. 1, pp. 1613-1627 . https://doi.org/10.18632/oncotarget.13693Subject Terms: RNA, Messenger/genetics, Male, 0301 basic medicine, Cell Movement, 80 and over, Adenoma, Oxyphilic, Casein Kinase II, Kidney Neoplasms/mortality, Aged, 80 and over, 0303 health sciences, Tumor, Oxyphilic/mortality, Renal Cell/mortality, Middle Aged, Kidney Neoplasms, 3. Good health, Carcinoma, Renal Cell/mortality, CK2-targeted therapy, Renal cancer, Tumor/genetics, Adenoma, Oxyphilic/mortality, CK2 subunits, Female, Biomarkers, Tumor/genetics, Research Paper, Adenoma, Adult, Naphthyridines/pharmacology, Cell Line, Cell Proliferation/genetics, 03 medical and health sciences, Cell Line, Tumor, Cell Movement/genetics, Biomarkers, Tumor, Humans, Neoplasm Invasiveness, Protein kinase CK2, RNA, Messenger, Naphthyridines, Carcinoma, Renal Cell, Aged, Cell Proliferation, CX-4945, Carcinoma, Casein Kinase II/antagonists & inhibitors, RNA, Messenger/genetics, Phenazines, Neoplasm Invasiveness/genetics, Biomarkers
File Description: application/pdf
Access URL: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=13693&path%5B%5D=43514
https://pubmed.ncbi.nlm.nih.gov/27906674
http://zaguan.unizar.es/record/61712
https://findresearcher.sdu.dk:8443/ws/files/124362611/Nuclear_localization_of_the_CK2a_subunit_correlates_with_poor_prognosis_in_clear_cell_renal_cell_carcinoma.pdf -
20
Authors: et al.
Contributors: et al.
Source: International Urology and Nephrology. 48:985-992
Subject Terms: Male, Neutrophils, Molecular Targeted Therapy, Kidney Neoplasms/mortality, Renal Cell/secondary, Prognostic factors, Nephrectomy, Kidney Neoplasms/therapy, Cohort Studies, 03 medical and health sciences, 0302 clinical medicine, Asian People, Republic of Korea, Kidney Neoplasms/pathology, Humans, Lymphocyte Count, Lymphocytes, 10. No inequality, Carcinoma, Renal Cell, Asian Continental Ancestry Group, Renal Cell/mortality, Carcinoma, Renal Cell/therapy, Prognosis, 16. Peace & justice, Renal cell carcinoma, Kidney Neoplasms, 3. Good health, Survival Rate, Female
File Description: 985~992
Access URL: https://pubmed.ncbi.nlm.nih.gov/26946137
https://link.springer.com/article/10.1007/s11255-016-1252-9
https://ir.ymlib.yonsei.ac.kr/handle/22282913/147069
https://yonsei.pure.elsevier.com/en/publications/comprehensive-analysis-and-validation-of-contemporary-survival-pr
http://europepmc.org/abstract/MED/26946137
https://mdanderson.elsevierpure.com/en/publications/comprehensive-analysis-and-validation-of-contemporary-survival-pr
Full Text 
Full Text Finder 
Nájsť tento článok vo Web of Science